{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Even Without Subsidies, EVs Still Cheaper Than Gasoline Cars Long Term

November 11, 2025Recent research has revealed that electric cars are still more affordable than internal combustion engine (ICE) cars over the long term despite the federal $7,500 rebate for EVs being phased out. The Big Beautiful Bill fundamentally altered the EV ownership equation and raised questions about whether gasoline cars now make more economic sense.


Gold on Course to Equal its Stellar Performance From the 70s

November 11, 2025Last week, gold’s price hovered around $4,000 an ounce, showing little movement after the sharp decline seen last month and prompting fresh debate about its future trajectory. Despite the recent dip, the metal is still on course for its strongest annual performance since the 70s.


Indian High Court Recognizes XRP as Property

November 11, 2025Many governments around the world are still grappling with how to regulate cryptocurrencies, leaving them in a legal gray zone. However, a growing number of countries have begun defining digital assets as property, a move that clarifies ownership rights and integrates them into existing tax systems.


MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Launches HOPE Therapeutics’ One-Day TMS Protocol for Treatment-Resistant Depression in Florida

November 10, 2025NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa “one day” (ONE-D) protocol for treatment-resistant depression—the first deployment of its kind in Florida and among the first nationwide. The Ampa device combines a single day of transcranial magnetic stimulation (TMS) with physician-prescribed D-cycloserine and lisdexamfetamine, which in peer-reviewed studies have shown response rates of 87% and remission rates of 72% in nonrandomized trials.


InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FRA: GDT0) Partners with Quaestor Federal Consulting to Form Sekur National Security Team

November 10, 2025This article has been disseminated on behalf of Sekur Private Data and may include paid advertising. Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0), a Swiss-hosted cybersecurity and private communications platform, announced a partnership with Quaestor Federal Consulting to establish the Sekur National Security Team (“NST”).


AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) CEO Discusses AI-Driven Cancer Drug Development in FintechTV Interview at NYSE

November 10, 2025• Lantern’s AI platform “learns, reads, models, and predicts” to identify new drugs and indications • CEO Panna Sharma says AI is compressing development timelines and cost structures across oncology Lantern Pharma (NASDAQ: LTRN), an AI-driven cancer drug developer, is using large-scale machine learning to discover new therapies, reposition existing molecules, and target high-unmet-need oncology indications. CEO Panna Sharma told FintechTV the company’s proprietary platform now self-learns, reads scientific papers, models molecules, predicts patient response, and suggests new indications — significantly reducing the time and cost of drug development.